CN103585444A - Adjuvant pharmaceutical composition for treating goiter - Google Patents
Adjuvant pharmaceutical composition for treating goiter Download PDFInfo
- Publication number
- CN103585444A CN103585444A CN201310570358.3A CN201310570358A CN103585444A CN 103585444 A CN103585444 A CN 103585444A CN 201310570358 A CN201310570358 A CN 201310570358A CN 103585444 A CN103585444 A CN 103585444A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- pharmaceutical composition
- thyromegaly
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses adjuvant pharmaceutical composition for treating goiter. The adjuvant pharmaceutical composition is prepared by semen brassicae, selfheal, radix ophiopogonis, radix scrophulariae, pinellia ternata, radix pseudostellariae, astragalus and roots of red-rooted salvia in a certain weight ratio. The adjuvant pharmaceutical composition has functions of inducing diuresis to alleviate edema, eliminating toxin and promoting tissue regeneration, and is used for adjuvant therapy of the goiter, good in effect and high in safety.
Description
Background technology
Thyroid disease onset is slow, and its outstanding clinical manifestation is thyromegaly, is generally moderate anthorisma, and matter is tough or harder, also can be the symptoms such as nodositas, has greatly affected patient's physical and mental health.Nowadays, along with the change of rhythm of life, operating pressure strengthens and excessive iodine is taken in, and causes its sickness rate soaring year by year.Because the pathogeny of primary disease is not clear so far, existing oneself causes the great attention of the world of medicine and relevant departments.
Chinese medicine and doctor trained in Western medicine are having significant progress aspect treatment thyromegaly in recent years, but after having patient to take, breathe hard, the symptom such as unable occurs, makes patient be not easy to adhere to treatment.
Summary of the invention
The technical problem to be solved of invention is to provide a kind of effectively pharmaceutical composition of auxiliary treatment thyromegaly, use this pharmaceutical composition, can effectively treat breathing hard of occurring, the symptom such as unable when taking the medicine for the treatment of thyromegaly, effective, safe.
For solving the problems of the technologies described above, the invention provides a kind of ancillary drug compositions for the treatment of thyromegaly, it is to be made by the crude drug in following weight range: 10-20 grams of Semen Sinapis Albaes, 10-20 grams of Spica Prunellaes, 8-15 grams of Radix Ophiopogonis, 10-20 grams of Radix Scrophulariaes, 8-15 grams of the Rhizoma Pinelliaes, 10-20 grams of Radix Pseudostellariaes, 25-35 grams of the Radixs Astragali, 10-20 grams of Radix Salviae Miltiorrhizaes.
As optimization, the ancillary drug compositions of described treatment thyromegaly is made by the crude drug in following weight range: 15 grams of Semen Sinapis Albaes, 15 grams of Spica Prunellaes, 10 grams of Radix Ophiopogonis, 15 grams of Radix Scrophulariaes, 10 grams of the Rhizoma Pinelliaes, 15 grams of Radix Pseudostellariaes, 30 grams of the Radixs Astragali, 15 grams of Radix Salviae Miltiorrhizaes.
Ancillary drug compositions of the present invention selects Semen Sinapis Albae, Spica Prunellae, Radix Ophiopogonis, Radix Scrophulariae, the Rhizoma Pinelliae, Radix Pseudostellariae, the Radix Astragali, Radix Salviae Miltiorrhizae to combine, by these drug regimens, make each efficacy of drugs produce synergism, thus effective auxiliary treatment thyromegaly.
Semen Sinapis Albae, nature and flavor are pungent, and temperature is nontoxic, enters lung, liver, spleen, stomach, pericardium channel, has promoting the circulation of QI eliminating phlegm, and the function of reducing swelling and alleviating pain is controlled phlegm retention cough with asthma, fullness and distention in the chest and hypochondrium pain, regurgitation vomiting, aphasia due to apoplexy, limbs arthralgia pain is numb, beriberi, carbuncle of yin nature, toxic swelling, treating swelling and pain by traumatic injury.
Spica Prunellae, nature and flavor bitter, acrid, cold.Enter liver, gallbladder meridian, have the function of liver heat removing, eliminating stagnation, diuresis, control the effects such as pestilence, acute mastitis, ophthalmalgia, jaundice, gonorrhea, hypertension.
Radix Ophiopogonis, property sweet and slightly bitter taste, cold, enter lung, stomach, heart channel, there is nourishing YIN and moistening the lung, the relieving restlessness that clears away heart-fire, the function of reinforcing stomach reg fluid, controls dryness of the lung dry cough, spits blood, spitting of blood, consumptive lung disease, lung abscess, asthenia dysphoria with smothery sensation, thirsty clearly, calentura Tianjin wound, dry mouth and throat, constipation.
Radix Scrophulariae, nature and flavor are bitter salty cool, have YIN nourishing, pathogenic fire reducing, relieving restlessness, the function of removing toxic substances, controls calentura excessive thirst, laryngopharynx swelling and pain, carbuncle scrofula.
The Rhizoma Pinelliae, nature and flavor are pungent, and temperature is poisonous, enters spleen, stomach warp, has drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, the function of dissolving lump and resolving mass, controls damp-phlegm cold drink, vomiting, regurgitation, cough with asthma abundant expectoration, chest and diaphragm distension, syncope due to accumulation of phlegm headache, dizzy sleeplessness, outer subduing inflammation.
Radix Pseudostellariae, nature and flavor sweetness and bitterness, tepor, enters the heart, spleen, lung three warps, has the function of tonifying the lung, spleen invigorating, controls cough due to deficiency of the lung, insufficiency of the spleen lack of appetite, cardiopalmus and antiperspirant, spirit is tired.
The Radix Astragali, nature and flavor are sweet, and tepor enters lung, spleen channel, raw with the useful consolidating superficial resistance of defending, inducing diuresis to remove edema, poison holding, the function of granulation promoting, controls spontaneous perspiration, night sweat, arthralgia due to stagnation of blood, edema, carbuncle is not burst or is burst and hold back for a long time; Process by the function that has invigorating the spleen and replenishing QI, control internal injury overstrain, diarrhea due to hypofunction of the spleen, proctoptosis, deficiency of vital energy blood prostration, the disease of metrorrhagia and leukorrhagia and all weakness of QI blood deficiency.
Radix Salviae Miltiorrhizae, nature and flavor are bitter, and tepor, enters the heart, Liver Channel, has blood circulation and promoting silt, calming heart and tranquilizing mind, evacuation of pus, the function of pain relieving, controls angina cordis, menoxenia, dysmenorrhea, to close, metrorrhagia leukorrhagia, leprosy abdominal mass, gathers, abdominal pain due to blood stasis, arthralgia, palpitation with fear sleeplessness, malignant boil toxic swelling.
Ancillary drug compositions of the present invention has the function that benefit is defended consolidating superficial resistance, inducing diuresis to remove edema, promoting the production of body fluid and benefiting QI, for auxiliary treatment thyromegaly, can effectively treat breathing hard of occurring, the symptom such as unable when taking the medicine for the treatment of thyromegaly, effective, safe, human body is not had to harm.
The preparation method of ancillary drug compositions that the present invention treats thyromegaly is simple, by each medicine of described weight proportion put into the container of boiling medicine add water routinely the decocting method of Chinese medicine decoct,, morning and evening every day takes for twice.
The specific embodiment
By test example, further set forth ancillary drug compositions of the present invention below.
The ancillary drug compositions for the treatment of thyromegaly, is made by the crude drug in following weight range: 15 grams of Semen Sinapis Albaes, 15 grams of Spica Prunellaes, 10 grams of Radix Ophiopogonis, 15 grams of Radix Scrophulariaes, 10 grams of the Rhizoma Pinelliaes, 15 grams of Radix Pseudostellariaes, 30 grams of the Radixs Astragali, 15 grams of Radix Salviae Miltiorrhizaes.
After decocting according to conventional decocting for Chinese herbal medicine method, to patient, sooner or later take.
By ancillary drug compositions auxiliary treatment thyromegaly patient of the present invention 50 examples, wherein 30 examples are carried out conventional therapy, 20 examples by doctor's advice treatment by Chinese herbs by doctor's advice with Western medicine, result is not to taking effective 38 examples of improvement of breathing hard of occurring before the present invention, the symptom such as unable, 10 examples take a turn for the better, invalid 2 examples, obvious effective rate 76%, improvement rate 20%, total effective rate is 96%, illustrate that the present invention has good promotional value, can help patient to remove misery, the treatment of thyromegaly can be carried through to the end, for curing thyromegaly, provide effective assurance.
Claims (2)
1. an ancillary drug compositions for the treatment of thyromegaly, is characterized in that: it is to be made by the crude drug in following weight range: 10-20 grams of Semen Sinapis Albaes, 10-20 grams of Spica Prunellaes, 8-15 grams of Radix Ophiopogonis, 10-20 grams of Radix Scrophulariaes, 8-15 grams of the Rhizoma Pinelliaes, 10-20 grams of Radix Pseudostellariaes, 25-35 grams of the Radixs Astragali, 10-20 grams of Radix Salviae Miltiorrhizaes.
2. the ancillary drug compositions for the treatment of thyromegaly according to claim 1, is characterized in that: it is to be made by the crude drug in following weight range: 15 grams of Semen Sinapis Albaes, 15 grams of Spica Prunellaes, 10 grams of Radix Ophiopogonis, 15 grams of Radix Scrophulariaes, 10 grams of the Rhizoma Pinelliaes, 15 grams of Radix Pseudostellariaes, 30 grams of the Radixs Astragali, 15 grams of Radix Salviae Miltiorrhizaes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310570358.3A CN103585444A (en) | 2013-11-17 | 2013-11-17 | Adjuvant pharmaceutical composition for treating goiter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310570358.3A CN103585444A (en) | 2013-11-17 | 2013-11-17 | Adjuvant pharmaceutical composition for treating goiter |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103585444A true CN103585444A (en) | 2014-02-19 |
Family
ID=50075897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310570358.3A Pending CN103585444A (en) | 2013-11-17 | 2013-11-17 | Adjuvant pharmaceutical composition for treating goiter |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103585444A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112316031A (en) * | 2020-12-04 | 2021-02-05 | 玉林市卫生学校附属医院 | Composition for treating hypothyroidism |
-
2013
- 2013-11-17 CN CN201310570358.3A patent/CN103585444A/en active Pending
Non-Patent Citations (1)
Title |
---|
胡齐鸣等: "徐蓉娟治疗甲状腺疾病经验", 《辽宁中医杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112316031A (en) * | 2020-12-04 | 2021-02-05 | 玉林市卫生学校附属医院 | Composition for treating hypothyroidism |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102423402B (en) | Traditional Chinese drug composition for treating night sweat | |
CN103536758B (en) | Traditional Chinese medicinal composition for treating night sweat due to yin deficiency | |
CN103055116B (en) | Traditional Chinese medicine composition for treating acnes | |
CN104984316A (en) | Medicine for treating female cold in uterus | |
CN103432390A (en) | Medicament for treating coronary heart disease and preparation method thereof | |
CN103349757A (en) | Traditional Chinese medicine composition for treating fire excess from yin deficiency | |
CN105535390A (en) | Traditional Chinese medicine decoction for treating coronary heart disease and preparation method of traditional Chinese medicine decoction | |
CN101095828A (en) | Chinese traditional medicine composition for treating diabetes constipation | |
CN103330854B (en) | Traditional Chinese medicine composition for treating nasal hemorrhage | |
CN103041271B (en) | Traditional Chinese medicine composition for treating emphysema | |
CN101780220B (en) | Traditional Chinese medicine for treating chronic gastritis | |
CN101129841A (en) | Traditional Chinese medicine composition for treating self-output of latex | |
CN103816366B (en) | A kind of medicine treating oral ulcer | |
CN103585444A (en) | Adjuvant pharmaceutical composition for treating goiter | |
CN103110911B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
CN104547369A (en) | Oral medicine for treating blepharospasm and preparation method thereof | |
CN101085313A (en) | Traditional Chinese medicine preparation for treating vicarious menstruation | |
CN103330814A (en) | Traditional Chinese medicine composition for treating deficiency of kidney yang | |
CN103432544B (en) | Decoction for treating upper gastrointestinal hemorrhage | |
CN102772723A (en) | Chinese medicinal prescription for treating phthisis | |
CN102406879A (en) | Chinese medicine composition for treating rhinitis | |
CN101912488A (en) | Chinese medicinal herb for treating hypomenorrhea | |
CN106620359A (en) | Medicine for treating acute nephritis and preparation method thereof | |
CN105816603A (en) | Traditional Chinese medicine composition for treating postpartum hemorrhage | |
CN105106759A (en) | Orally-taken medicine for treating psoriasis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140219 |